docetaxel has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iimura, S; Ishiyama, T; Ohsuki, S; Soga, T; Terasawa, H; Uoto, K | 1 |
| Chen, J; He, Q; Hu, Y; Lu, X; Wu, R; Xue, N; Yang, B; Yang, X | 1 |
| Cai, Q; Guo, M; Kang, S; Leopold, L; Liu, L; Lu, J; McEachern, D; Miller, R; Nikolovska-Coleska, Z; Peng, Y; Qiu, S; Sun, D; Sun, H; Wang, S; Yang, CY; Yang, D; Yi, H; Zhang, T | 1 |
| Bernard, Y; Cresteil, T; Désaubry, L; Gaiddon, C; Hild, A; Hirsch, EC; Michel, PP; Nebigil, CG; Ribeiro, N; Thuaud, F | 1 |
| Akula, B; Bharathi, EV; Billa, VK; Cosenza, SC; Gallo, JM; Lv, H; Mallireddigari, MR; Padgaonkar, A; Pallela, VR; Reddy, EP; Reddy, MV; Subbaiah, DR | 1 |
| Barasoain, I; Carda, M; Díaz, JF; Díaz-Oltra, S; Falomir, E; Marco, JA; Murga, J; Redondo-Horcajo, M; Vilanova, C | 1 |
| Cui, J; Cui, Q; Li, S; Meng, Q; Zhang, X; Zhou, W | 1 |
7 other study(ies) available for docetaxel and Neoplasms
| Article | Year |
|---|---|
New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals.
Topics: Acetals; Antineoplastic Agents; Docetaxel; Drug Screening Assays, Antitumor; Humans; Neoplasms; Paclitaxel; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 2002 |
Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Imidazoles; Mice; Molecular Structure; Neoplasm Transplantation; Neoplasms; Structure-Activity Relationship | 2008 |
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Area Under Curve; Azocines; Benzhydryl Compounds; Biological Availability; Cell Line, Tumor; Humans; Inhibitor of Apoptosis Proteins; Models, Molecular; Neoplasms | 2011 |
Flavaglines as potent anticancer and cytoprotective agents.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Benzofurans; Biological Products; Cardiotonic Agents; Cells, Cultured; Cisplatin; Cytoprotection; Disease Models, Animal; Dopaminergic Neurons; Doxorubicin; Humans; Mice; Models, Molecular; Molecular Structure; Myocytes, Cardiac; Neoplasms; Parkinson Disease; Rats; Structure-Activity Relationship | 2012 |
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Design; Drug Resistance, Neoplasm; HCT116 Cells; Humans; K562 Cells; MCF-7 Cells; Mice; Mice, Nude; Microtubules; Neoplasms; Polymerization; Sulfonamides; Tubulin; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulin.
Topics: Antineoplastic Agents; Binding Sites; Cell Proliferation; Colchicine; Drug Design; Fluorescent Antibody Technique; Humans; Microtubules; Molecular Structure; Neoplasms; Pyrones; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured | 2014 |
Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
Topics: Antineoplastic Agents; Benzoflavones; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Docetaxel; Drug Resistance, Neoplasm; Humans; Molecular Docking Simulation; Neoplasms; Taxoids | 2015 |